The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
CHRONIC COR PULMONALE
Open accessAbstract
he term "cor pulmonale" is still very popular in the medical literature, but its definition varies and there is presently no consensual definition.Forty years ago an expert committee of the World Health Organization 1 defined cor pulmonale as "hypertrophy of the right ventricle resulting from diseases affecting the function and/or structure of the lungs . ..".This pathological definition is in fact of limited value in clinical practice.It has been proposed to replace the term "hypertrophy" by "alteration in the structure and function of the right ventricle".It has also been proposed to define clinically cor pulmonale by the presence of oedema in patients with respiratory failure.Finally, as pulmonary arterial hypertension is "the sine qua non" of cor pulmonale, 2 we believe that the best definition of cor pulmonale is : pulmonary arterial hypertension resulting from diseases affecting the structure and/or the function of the lungs; pulmonary arterial hypertension results in right ventricular enlargement (hypertrophy and/or dilatation) and may lead with time to right heart failure.A new diagnostic classification of pulmonary hypertension was developed by a group of experts in 1998 3 and is presented on table 1.In our opinion cor pulmonale corresponds to the third part of this classification (pulmonary hypertension associated with disorders of the respiratory system and/or hypoxaemia) and must be distinguished from pulmonary venous hypertension (part 2), and also from primary pulmonary hypertension (part 1) and from thromboembolic pulmonary hypertension (part 4).This article reviews the current state of knowledge about pulmonary hypertension resulting from disorders of the respiratory system and/or from chronic hypoxaemia.We will only consider chronic cor pulmonale.Particular emphasis will be placed on chronic obstructive pulmonary disease (COPD) which is by far the main cause of cor pulmonale. c DEFINITIONS AND EPIDEMIOLOGYPulmonary hypertension complicating chronic respiratory disease is generally defined by the presence of a resting mean pulmonary artery pressure (PAP) > 20 mm Hg.This is slightly different from the definition of primary pulmonary hypertension (PAP > 25 mmHg).3 In young (< 50 years) healthy subjects PAP is most often between 10-15 mm Hg.With aging there is a slight increase in PAP, by about 1 mm Hg/10 years.A resting PAP > 20 mm Hg is always abnormal.In the "natural history" of COPD, pulmonary hypertension is often preceded by an abnormally large increase in PAP during exercise, defined by a pressure > 30 mm Hg for a mild level of steady state exercise.The term "exercising" pulmonary hypertension has been used by some authors, but the term "pulmonary hypertension" should be reserved for resting pulmonary hypertension.Cor pulmonale is a common type of heart disease, as a result of its close association with COPD which has emerged, in recent years, as a leading cause of disability and death.4 But there are in fact very few data about the incidence and prevalence of cor pulmonale.The main reason is that right heart catheterisation cannot be performed on a large scale in patients at risk.An alternative approach is the use of non-invasive methods, particularly Doppler echocardiography.It should be possible to investigate large groups of respiratory patients with echo Doppler within the next few years.A UK study performed in Sheffield 5 has tried to determine the prevalence of patients at risk of developing pulmonary hypertension and cor pulmonale-that is, patients with hypoxaemic lung disease.In the study population, aged > 45 years, an estimated 0.3% had both an arterial oxygen tension (PaO 2 ) < 7.3 kPa (55 mm Hg) and a forced expiratory volume in one second (FEV 1 ) < 50% of the predicted value.For England and Wales this could represent 60 000 subjects at risk of pulmonary hypertension and eligible for long term oxygen therapy.The mortality related to cor pulmonale is also difficult to assess.There are data about the mortality resulting from chronic lung disease (100 000/year in the USA 4 ) but we do not know precisely the role of secondary pulmonary hypertension in this mortality.Pulmonary hypertension is a complication, among others, of advanced COPD and it is not possible to separate it from its causative diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Cited by
Pulmonary hypertension in COPD
Chaouat, A., Naeije, R., & Weitzenblum, E. (2008) · European Respiratory Journal · doi:10.1183/09031936.00015608 · Cited by 625
Self-citationTietjens, J. R., Claman, D., Kezirian, E. J., De Marco, T., Mirzayan, A., Sadroonri, B., Goldberg, A. N., Long, C., Gerstenfeld, E. P., & Yeghiazarians, Y. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.010440 · Cited by 397
Price, L. C., Wort, S. J., Finney, S. J., Marino, P. S., & Brett, S. J. (2010) · Critical Care · doi:10.1186/cc9264 · Cited by 389
Lin, G., Nishimura, R. A., Connolly, H. M., Dearani, J. A., Sundt, T. M., & Hayes, D. L. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.02.037 · Cited by 361
Haemodynamic evaluation of pulmonary hypertension
Chemla, D., Castelain, V., Hervé, P., Lecarpentier, Y., & Brimioulle, S. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00068002 · Cited by 337
Metadata
- Authors
- Weitzenblum, E.
- Venue
- Heart
- Publisher
- BMJ
- Published
- 2003-02
- Volume
- 89
- Issue
- 2
- Pages
- 225-230
- ISSN
- 1355-6037 (ISSN-L)
- 1468-201X
- OpenAlex
- W1977021680
- Cited by
- 218
- References
- 1
- FWCI
- 8.35
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CHRONIC COR PULMONALE. https://app.cochat.ai/papers/10.1136/heart.89.2.225
- The paper
- Weitzenblum, E. (2003). CHRONIC COR PULMONALE. Heart. https://doi.org/10.1136/heart.89.2.225
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.